Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Dare Bioscience (DARE) over the last 10 years, with Q3 2025 value amounting to $3.7 million.

  • Dare Bioscience's Operating Expenses fell 2220.24% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year decrease of 3067.33%. This contributed to the annual value of $23.5 million for FY2024, which is 3048.05% down from last year.
  • Dare Bioscience's Operating Expenses amounted to $3.7 million in Q3 2025, which was down 2220.24% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's Operating Expenses ranged from a high of $16.2 million in Q4 2022 and a low of $3.7 million during Q3 2025
  • Moreover, its 5-year median value for Operating Expenses was $7.4 million (2024), whereas its average is $7.9 million.
  • In the last 5 years, Dare Bioscience's Operating Expenses surged by 7007.62% in 2022 and then tumbled by 5699.88% in 2023.
  • Over the past 5 years, Dare Bioscience's Operating Expenses (Quarter) stood at $9.5 million in 2021, then surged by 70.08% to $16.2 million in 2022, then crashed by 57.0% to $7.0 million in 2023, then fell by 23.71% to $5.3 million in 2024, then tumbled by 30.99% to $3.7 million in 2025.
  • Its last three reported values are $3.7 million in Q3 2025, $3.8 million for Q2 2025, and $4.6 million during Q1 2025.